ABPI response to the new Northern Ireland Brexit deal

The Prime Minister confirmed today that the new Windsor Framework would ensure medicines approved for use by the UK regulator will automatically become available in Northern Ireland.

Richard Torbett, Chief Executive at the ABPI said: “While we wait to see all the details, today’s agreement appears to bring a return to a single UK market for medicines, providing the permanent solution that our members have been calling for.

“Pharmaceutical companies will now need the right amount of time to make all necessary changes, and we will need to carefully consider the transition period for making these changes and to ensure any new guidance is clear and provided as soon as possible.

“Alongside the measures specific to medicine regulation, it’s great news that the work on the UK’s association to Horizon Europe can begin, which will help to deliver the UK’s ambition to be a science superpower.”